Relationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adults

Paula T Trzepacz, Helen Hochstetler, Shufang Wang, Brett Walker, Andrew J Saykin, Alzheimer’s Disease Neuroimaging Initiative

Abstract

Background: The Montreal Cognitive Assessment (MoCA) was developed to enable earlier detection of mild cognitive impairment (MCI) relative to familiar multi-domain tests like the Mini-Mental State Exam (MMSE). Clinicians need to better understand the relationship between MoCA and MMSE scores.

Methods: For this cross-sectional study, we analyzed 219 healthy control (HC), 299 MCI, and 100 Alzheimer's disease (AD) dementia cases from the Alzheimer's Disease Neuroimaging Initiative (ADNI)-GO/2 database to evaluate MMSE and MoCA score distributions and select MoCA values to capture early and late MCI cases. Stepwise variable selection in logistic regression evaluated relative value of four test domains for separating MCI from HC. Functional Activities Questionnaire (FAQ) was evaluated as a strategy to separate dementia from MCI. Equi-percentile equating produced a translation grid for MoCA against MMSE scores. Receiver Operating Characteristic (ROC) analyses evaluated lower cutoff scores for capturing the most MCI cases.

Results: Most dementia cases scored abnormally, while MCI and HC score distributions overlapped on each test. Most MCI cases scored ≥ 17 on MoCA (96.3%) and ≥ 24 on MMSE (98.3%). The ceiling effect (28-30 points) for MCI and HC was less using MoCA (18.1%) versus MMSE (71.4%). MoCA and MMSE scores correlated most for dementia (r = 0.86; versus MCI r = 0.60; HC r = 0.43). Equi-percentile equating showed a MoCA score of 18 was equivalent to MMSE of 24. ROC analysis found MoCA ≥ 17 as the cutoff between MCI and dementia that emphasized high sensitivity (92.3%) to capture MCI cases. The core and orientation domains in both tests best distinguished HC from MCI groups, whereas comprehension/executive function and attention/calculation were not helpful. Mean FAQ scores were significantly higher and a greater proportion had abnormal FAQ scores in dementia than MCI and HC.

Conclusions: MoCA and MMSE were more similar for dementia cases, but MoCA distributes MCI cases across a broader score range with less ceiling effect. A cutoff of ≥ 17 on the MoCA may help capture early and late MCI cases; depending on the level of sensitivity desired, ≥ 18 or 19 could be used. Functional assessment can help exclude dementia cases. MoCA scores are translatable to the MMSE to facilitate comparison.

Figures

Fig. 1
Fig. 1
Scatterplots for MMSE and MoCA scores shown by diagnostic group. Graphs are for all subjects (a), dementia only (b), MCI only (c) and HC only (d). Pearson correlation coefficients between MMSE and MoCA scores are shown for each graph. Vertical lines denote MMSE standard cutoff of 24 points and horizontal lines denote different proposed MoCA cutoffs for MCI (17, 19 and 23). Note that symbols may represent more than one case at that score
Fig. 2
Fig. 2
MoCA mapped to MMSE scores using equi-percentile equating method with log-linear smoothing in 618 subjects. Lines in graphs indicate MMSE cutoff of 24 and MoCA cutoffs of 17 and 19. The MoCA value equivalent to a MMSE cutoff of 24 is shaded
Fig. 3
Fig. 3
ROC analysis graph of MoCA scores for distinguishing MCI subjects (n = 299) from the AD dementia group (n = 100) and table for MoCA values to consider as lower cutoff values for MCI (17–20) depending on sensitivity and specificity levels preferred in a given situation

References

    1. Galvin JE, Sadowsky CH, NINCDS-ADRDA Practical guidelines for the recognition and diagnosis of dementia. J Am Board Fam Med. 2012;25(3):367–82. doi: 10.3122/jabfm.2012.03.100181.
    1. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–98. doi: 10.1016/0022-3956(75)90026-6.
    1. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–9. doi: 10.1111/j.1532-5415.2005.53221.x.
    1. Vertesi A, Lever JA, Molloy DW, Sanderson B, Tuttle I, Pokoradi L, et al. Standardized Mini-Mental State Examination: use and interpretation. Can Fam Phys. 2001;47:2018–23.
    1. Spencer RJ, Wendell CR, Giggey PP, Katzel LI, Lefkowitz DM, Siegel EL, et al. Psychometric limitations of the Mini-mental State Examination among nondemented older adults: an evaluation of neurocognitive and magnetic resonance imaging correlates. Exp Aging Res. 2013;39(4):382–97. doi: 10.1080/0361073X.2013.808109.
    1. Lonie JA, Tierney KM, Ebmeier KP. Screening for mild cognitive impairment: a systematic review. Int J Geriatr Psychiatry. 2009;24(9):902–15. doi: 10.1002/gps.2208.
    1. Beatty WW, Goodkin DE. Screening for cognitive impairment in multiple sclerosis. An evaluation of the Mini-Mental State Examination. Arch Neurol. 1990;47(3):297–301. doi: 10.1001/archneur.1990.00530030069018.
    1. Swirsky-Sacchetti T, Field HL, Mitchell DR, Seward J, Lublin FD, Knobler RL, et al. The sensitivity of the Mini-Mental State Exam in the white matter dementia of multiple sclerosis. J Clin Psychol. 1992;48(6):779–86. doi: 10.1002/1097-4679(199211)48:6<779::AID-JCLP2270480612>;2-B.
    1. Moser DJ, Cohen RA, Clark MM, Aloia MS, Tate BA, Stefanik S, et al. Neuropsychological functioning among cardiac rehabilitation patients. J Cardiopulm Rehabil. 1999;19(2):91–7. doi: 10.1097/00008483-199903000-00002.
    1. Tombaugh TN, McIntyre NJ. The Mini-Mental State Examination: A comprehensive review. J Am Geriatr Soc. 1992;40(9):922–35. doi: 10.1111/j.1532-5415.1992.tb01992.x.
    1. Imtiaz B, Tolppanen AM, Kivipelto M, Soininen H. Future directions in Alzheimer’s disease from risk factors to prevention. Biochem Pharmacol. 2014;88(4):661–70. doi: 10.1016/j.bcp.2014.01.003.
    1. Luis CA, Keegan AP, Mullan M. Cross validation of the Montreal Cognitive Assessment in community dwelling older adults residing in the Southeastern US. Int J Geriatr Psychiatry. 2009;24(2):197–201. doi: 10.1002/gps.2101.
    1. Freitas S, Simões MR, Alves L, Santana I. Montreal Cognitive Assessment: validation study for mild cognitive impairment and Alzheimer disease. Alzheimer Dis Assoc Disord. 2013;27(1):37–43. doi: 10.1097/WAD.0b013e3182420bfe.
    1. Roalf DR, Moberg PJ, Xie SX, Wolk DA, Moelter ST, Arnold SE. Comparative accuracies of two common screening instruments for classification of Alzheimer’s disease, mild cognitive impairment, and healthy aging. Alzheimers Dement. 2013;9(5):529–37. doi: 10.1016/j.jalz.2012.10.001.
    1. Pendlebury ST, Cuthbertson FC, Welch SJ, Mehta Z, Rothwell PM. Underestimation of cognitive impairment by Mini-Mental State Examination versus the Montreal Cognitive Assessment in patients with transient ischemic attack and stroke: a population-based study. Stroke. 2010;41(6):1290–3. doi: 10.1161/STROKEAHA.110.579888.
    1. Nazem S, Siderowf AD, Duda JE, Have TT, Colcher A, Horn SS, et al. Montreal Cognitive Assessment performance in patients with Parkinson’s disease with “normal” global cognition according to Mini-mental State Examination score. J Am Geriatr Soc. 2009;57(2):304–8. doi: 10.1111/j.1532-5415.2008.02096.x.
    1. Lam B, Middleton LE, Masellis M, Stuss DT, Harry RD, Kiss A, et al. Criterion and convergent validity of the Montreal Cognitive Assessment with screening and standardized neuropsychological testing. J Am Geriatr Soc. 2013;61(12):2181–5. doi: 10.1111/jgs.12541.
    1. Godefroy O, Fickl A, Roussel M, Auribault C, Bugnicourt JM, Lamy C, et al. Is the Montreal Cognitive Assessment superior to the Mini-Mental State Examination to detect poststroke cognitive impairment? A study with neuropsychological evaluation. Stroke. 2011;42(6):1712–6. doi: 10.1161/STROKEAHA.110.606277.
    1. Risacher SL, Kim S, Shen L, Nho K, Foroud T, Green RC, et al. The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI) Front Aging Neurosci. 2013;5:11. doi: 10.3389/fnagi.2013.00011.
    1. Bondi MW, Edmonds EC, Jak AJ, Clark LR, Delano-Wood L, McDonald CR, et al. Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates. J Alzheimers Dis. 2014;42(1):275–89.
    1. McLennan SN, Mathias JL, Brennan LC, Stewart S. Validity of the Montreal Cognitive Assessment (MoCA) as a screening test for mild cognitive impairment (MCI) in a cardiovascular population. J Geriatr Psychiatry Neurol. 2011;24(1):33–8. doi: 10.1177/0891988710390813.
    1. Whitney KA, Mossbarger B, Herman SM, Ibarra SL. Is the Montreal Cognitive Assessment superior to the Mini-mental State Examination in detecting subtle cognitive impairment among middle-aged outpatient U.S. Military veterans? Arch Clin Neuropsychol. 2012;27(7):742–8. doi: 10.1093/arclin/acs060.
    1. Weiner MW, Aisen PS, Jack CR, Jr, Jagust WJ, Trojanowski JQ, Shaw L, et al. Alzheimer’s Disease Neuroimaging Initiative: The Alzheimer’s Disease Neuroimaging Initiative: Progress report and future plans. Alzheimers Dement. 2010;6(3):202–11. doi: 10.1016/j.jalz.2010.03.007.
    1. Pfeffer RI, Kurosaki TT, Harrah CH, Jr, Chance JM, Filos S. Measurement of functional activities of older adults in the community. J Gerontol. 1982;37(3):323–9. doi: 10.1093/geronj/37.3.323.
    1. Kolen MJ, Brennan RL. Test equating, scaling and linking: Methods and practices. 2. New York, NY: Springer; 2006.
    1. Falkowski JA, Hynan LS, Krishnan K, Carter K, Lacritz L, Weiner M, et al. Conversion of MoCA to MMSE scores. Alzheimers Dement Diagn Assess Dis Monit. 2015;1(1):125. doi: 10.1016/j.dadm.2015.02.001.
    1. Amieva H, Mokri H, Le Goff M, Meillon C, Jacqmin-Gadda H, Foubert-Samier A, et al. Compensatory mechanisms in higher-educated subjects with Alzheimer’s disease: a study of 20 years of cognitive decline. Brain. 2014;137(Pt 4):1167–75. doi: 10.1093/brain/awu035.

Source: PubMed

3
Subscribe